NSE · BPLPHARMA
Bharat Parenterals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,430
of 5,004 stocks
▲ 1131W
Peak #1,424 · 27 Sep 2026
Operating in Healthcare, Bharat Parenterals Limited carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and remains firmly promoter-controlled, with promoters holding 67%.
Market Cap
1,235.60 Cr
P/E Ratio
45.25
P/B Ratio
3.97
ROE
-8.76%
ROCE
-1.95%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 93.74 Cr | 99.62 Cr | 65.19 Cr | 64.62 Cr |
| Net Profit | -3.56 Cr | -8.16 Cr | -9.67 Cr | -8.61 Cr |
| EPS | 5.17 | 11.84 | 14.03 | 14.00 |
| Operating Profit | 95.92 L | -5.53 Cr | -5.39 Cr | -4.21 Cr |
Shareholding pattern
Promoter
67.20%
Public
32.80%
Mutual fund holdings
₹0.39
Cr total
1
Schemes
1
Fund Houses
₹0.39 Cr
Total Exposure
WhiteOak Capital Mutual Fund₹0.39 Cr (100.0%)
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.